Johnson & Johnson (JNJ)
268.04
+2.27
(+0.85%)
USD |
NYSE |
Aug 28, 16:00
268.22
+0.18
(+0.07%)
After-Hours: 20:00
Johnson & Johnson Cash and Short Term Investments (Quarterly) : 20.76B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.76B |
| March 31, 2026 | 22.05B |
| December 31, 2025 | 20.10B |
| September 30, 2025 | 18.56B |
| June 30, 2025 | 18.88B |
| March 31, 2025 | 38.78B |
| December 31, 2024 | 24.52B |
| September 30, 2024 | 20.30B |
| June 30, 2024 | 25.48B |
| March 31, 2024 | 26.22B |
| December 31, 2023 | 22.93B |
| September 30, 2023 | 23.51B |
| June 30, 2023 | 28.50B |
| March 31, 2023 | 32.31B |
| December 31, 2022 | 22.28B |
| September 30, 2022 | 34.08B |
| June 30, 2022 | 32.57B |
| March 31, 2022 | 30.39B |
| December 31, 2021 | 31.61B |
| September 30, 2021 | 31.00B |
| June 30, 2021 | 25.31B |
| March 31, 2021 | 24.62B |
| December 31, 2020 | 25.18B |
| September 30, 2020 | 30.78B |
| June 30, 2020 | 19.14B |
| Date | Value |
|---|---|
| March 31, 2020 | 18.02B |
| December 31, 2019 | 19.29B |
| September 30, 2019 | 17.94B |
| June 30, 2019 | 15.28B |
| March 31, 2019 | 15.34B |
| December 31, 2018 | 19.69B |
| September 30, 2018 | 19.36B |
| June 30, 2018 | 18.14B |
| March 31, 2018 | 15.20B |
| December 31, 2017 | 18.30B |
| September 30, 2017 | 16.23B |
| June 30, 2017 | 12.85B |
| March 31, 2017 | 39.34B |
| December 31, 2016 | 41.91B |
| September 30, 2016 | 40.43B |
| June 30, 2016 | 42.58B |
| March 31, 2016 | 39.86B |
| December 31, 2015 | 38.38B |
| September 30, 2015 | 37.31B |
| June 30, 2015 | 33.95B |
| March 31, 2015 | 31.32B |
| December 31, 2014 | 33.09B |
| September 30, 2014 | 33.00B |
| June 30, 2014 | 31.62B |
| March 31, 2014 | 29.39B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.95B |
| Merck & Co., Inc. | 7.182B |
| Pfizer Inc. | 11.70B |
| Bristol Myers Squibb Co. | 11.07B |
| Liquidia Corp. | 284.18M |